This seminar focuses on the case study of human papillomavirus (HPV) vaccination in the UK. The HPV vaccine is now offered to girls and boys aged 12–13, as well as to men who have sex with men. The vaccine helps prevent cervical, head and neck, and anogenital cancers caused by HPV infection, as well as genital warts.
We have three expert speakers from across the science and policy spectrum. Professor Mark Jit will discuss the mathematical modelling research that informed HPV vaccination policy in the UK. Dr Peter Grove will discuss economic analysis and other considerations that guided decision-making around HPV vaccination in the UK. Finally, Dr Kate Soldan will present her work for UKHSA evaluating the HPV vaccine's impact.
This seminar will be followed by a short Q&A and is targeted towards anyone interested in the specific subject area as well as in the more general process by which academic research informs policy.
Speakers
- Dr Peter Grove
- Professor Mark Jit
- Dr Kate Soldan
-
Kate Soldan has an MPhil and PhD in epidemiology and has worked on surveillance and epidemiology to inform the design, implementation and evaluation of HPV vaccination since 2016. Prior to this, Kate worked on blood-borne infections and blood safety in the UK, on cancer epidemiology, and on surveillance of HIV and vaccine-preventable infections abroad
Admission
Contact
Where and when
LSHTM, Keppel Street
London
WC1E 7HT
United Kingdom
Admission
Contact
Events notices
For more information on how we use your data, please see our events privacy notice and our data protection pages.
LSHTM uses third-party platforms, which are not affiliated with LSHTM directly, to host our virtual events. Please see the Zoom privacy notice and Collaborate privacy notice for these.
For any accessibility requirements, please get in touch with the event contact listed above.
